{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:18:51Z","timestamp":1784974731056,"version":"3.55.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CiSA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00520-024-08872-x","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T05:01:50Z","timestamp":1727499710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bridging the gap \u2014 Establishing a dental-oncology service in a cancer centre"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7432-0945","authenticated-orcid":false,"given":"Harriet","family":"Byrne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7431-684X","authenticated-orcid":false,"given":"Claire","family":"Curtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4823-7392","authenticated-orcid":false,"given":"Catherine S.","family":"Weadick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1937-8105","authenticated-orcid":false,"given":"R\u00edcheal N\u00ed","family":"Riord\u00e1in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2887-7336","authenticated-orcid":false,"given":"Seamus","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"8872_CR1","unstructured":"bridge_1 noun - Definition, pictures, pronunciation and usage notes | Oxford Advanced American Dictionary at OxfordLearnersDictionaries.com. [Online]. Available: https:\/\/www.oxfordlearnersdictionaries.com\/definition\/american_english\/bridge_1.\u00a0Accessed\u00a027 Dec 2023"},{"key":"8872_CR2","unstructured":"WHO Discussion Paper: draft global strategy on oral health, dental health foundation. [Online]. Available: https:\/\/www.dentalhealth.ie\/news\/who-discussion-paper-draft-global-strategy-on-oral-health\/.\u00a0Accessed 28 Jun 2023"},{"issue":"1","key":"8872_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/prd.12323","volume":"82","author":"PI Eke","year":"2020","unstructured":"Eke PI, Borgnakke WS, Genco RJ (2020) Recent epidemiologic trends in periodontitis in the USA. Periodontol 2000 82(1):257\u2013267. https:\/\/doi.org\/10.1111\/prd.12323","journal-title":"Periodontol 2000"},{"issue":"8","key":"8872_CR4","doi-asserted-by":"publisher","first-page":"e725","DOI":"10.4317\/jced.56307","volume":"12","author":"R-D-G Caminha","year":"2020","unstructured":"Caminha R-D-G, Alcantara P-L, Carvalho C-G, Reia V-C-B, Capelozza A-L-A, Santos P-SS (2020) The impact of medication-related osteonecrosis of the jaws on the quality of life in cancer patients. J Clin Exp Dent 12(8):e725\u2013e729. https:\/\/doi.org\/10.4317\/jced.56307","journal-title":"J Clin Exp Dent"},{"issue":"2","key":"8872_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/01.mlr.0000108746.69256.45","volume":"42","author":"KP Weinfurt","year":"2004","unstructured":"Weinfurt KP, Castel LD, Li Y, Timbie JW, Glendenning GA, Schulman KA (2004) Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions. Med Care 42(2):164\u2013175. https:\/\/doi.org\/10.1097\/01.mlr.0000108746.69256.45","journal-title":"Med Care"},{"issue":"4","key":"8872_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/annonc\/mdi122","volume":"16","author":"KP Weinfurt","year":"2005","unstructured":"Weinfurt KP, Li Y, Schulman KA et al. (2005) The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. Ann Oncol 16(4):579\u2013584. https:\/\/doi.org\/10.1093\/annonc\/mdi122","journal-title":"Ann Oncol"},{"issue":"10","key":"8872_CR7","doi-asserted-by":"publisher","first-page":"CD003474","DOI":"10.1002\/14651858.CD003474.pub4","volume":"10","author":"B OCarrigan","year":"2017","unstructured":"OCarrigan B, Wong MH, Willson ML, Stockler MR, Pavlakis N, A, (2017) Goodwin, Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev. 10(10):CD003474. https:\/\/doi.org\/10.1002\/14651858.CD003474.pub4","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"8872_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","volume":"49","author":"RE Coleman","year":"2011","unstructured":"Coleman RE, McCloskey EV (2011) Bisphosphonates in oncology. Bone 49(1):71\u201376. https:\/\/doi.org\/10.1016\/j.bone.2011.02.003","journal-title":"Bone"},{"issue":"12","key":"8872_CR9","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","volume":"31","author":"R Coleman","year":"2020","unstructured":"Coleman R, Hadji P, Body JJ, SAntini D, Chow E, Terpos E, et al. (2020) Bone health in cancer: ESMO Clinical Practice Guidelines. Ann Oncol 31(12):1650\u20131663. https:\/\/doi.org\/10.1016\/j.annonc.2020.07.019","journal-title":"Ann Oncol"},{"issue":"7","key":"8872_CR10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/1097-0142(20010401)91:7<1191::aid-cncr1119>3.0.co;2-0","volume":"91","author":"JR Berenson","year":"2001","unstructured":"Berenson JR, Rosen LS, Howell A, Poerter L, Coleman RE, Morley W, et al.\u00a0(2001) Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer 91(7):1191\u20131200. https:\/\/doi.org\/10.1002\/1097-0142(20010401)91:7%3c1191::aid-cncr1119%3e3.0.co;2-0","journal-title":"Cancer"},{"issue":"5","key":"8872_CR11","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American Association of Oral and Maxillofacial Surgeons Position Paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg 80(5):920\u2013943. https:\/\/doi.org\/10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"key":"8872_CR12","doi-asserted-by":"publisher","unstructured":"S Yao, X Ding, G Rong, J Zhou, B. Zhang, Association between malignant diseases and medication-related osteonecrosis of the jaw (MRONJ): a systematic review and meta-analysis. J Craniofac Surg https:\/\/doi.org\/10.1097\/SCS.0000000000009033","DOI":"10.1097\/SCS.0000000000009033"},{"issue":"25","key":"8872_CR13","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/JCO.19.01186","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE, Van Posnak CH, Bohlke K, Ruggiero SL et al. (2019) Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline. JCO 37(25):2270\u20132290. https:\/\/doi.org\/10.1200\/JCO.19.01186","journal-title":"JCO"},{"issue":"2","key":"8872_CR14","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00520-021-06587-x","volume":"30","author":"C Bacci","year":"2022","unstructured":"Bacci C, Cerrato A, Bardhi E, Frigo AC, Djaballah SA, Sivolella S (2022) A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities. Support Care Cancer 30(2):1723\u20131729. https:\/\/doi.org\/10.1007\/s00520-021-06587-x","journal-title":"Support Care Cancer"},{"issue":"5","key":"8872_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","volume":"125","author":"AA Owosho","year":"2018","unstructured":"Owosho AA, Liang STY, Sax AZ, Wu K, Yom SK, Huryn JM et al.\u00a0(2018) Medication-related osteonecrosis of the jaw (MRONJ): an update on the Memorial Sloan Kettering Cancer Center (MSKCC) experience and the role of pre-medication dental evaluation in the prevention of MRONJ. Oral Surg Oral Med Oral Pathol Oral Radiol 125(5):440\u2013445. https:\/\/doi.org\/10.1016\/j.oooo.2018.02.003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"8872_CR16","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s00520-020-05748-8","volume":"29","author":"DA Kizub","year":"2021","unstructured":"Kizub DA, Miao J, Schubert MM, Paterson AHG, Clemons M, Dees EC et al.\u00a0(2021) Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307). Support Care Cancer 29(5):2509\u20132517. https:\/\/doi.org\/10.1007\/s00520-020-05748-8","journal-title":"Support Care Cancer"},{"issue":"9","key":"8872_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1470-2045(14)70302-X","volume":"15","author":"R Coleman","year":"2014","unstructured":"Coleman R, Cameron D, Dodwell D, Bell R, Wilson C, Rathbone E et al. (2014) Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01\/04) randomised open-label phase 3 trial. Lancet Oncol 15(9):997\u20131006. https:\/\/doi.org\/10.1016\/S1470-2045(14)70302-X","journal-title":"Lancet Oncol"},{"issue":"6","key":"8872_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/bcr2768","volume":"12","author":"M Gnant","year":"2010","unstructured":"Gnant M, Hadji P (2010) Prevention of bone metastases and management of bone health in early breast cancer. Breast Cancer Res 12(6):216. https:\/\/doi.org\/10.1186\/bcr2768","journal-title":"Breast Cancer Res"},{"issue":"1","key":"8872_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ccr3.3418","volume":"9","author":"A Guida","year":"2020","unstructured":"Guida A, Perri F, Ionna F, Ascierto PA, Grimaldi AM (2020) New-generation anticancer drugs and medication-related osteonecrosis of the jaw (MRONJ): late onset 3 years after ipilimumab endovenous administration with a possible role of target therapy. Clin Case Rep 9(1):61\u201366. https:\/\/doi.org\/10.1002\/ccr3.3418","journal-title":"Clin Case Rep"},{"key":"8872_CR20","doi-asserted-by":"publisher","unstructured":"M. Y, Is bevacizumab a direct cause of osteonecrosis of the jaw like bisphosphonate?, AJBSR, vol. 9, no. 1, pp. 71\u201372, Jun. 2020, https:\/\/doi.org\/10.34297\/AJBSR.2020.09.001354.","DOI":"10.34297\/AJBSR.2020.09.001354"},{"issue":"3","key":"8872_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijom.2019.08.007","volume":"49","author":"K Brijs","year":"2020","unstructured":"Brijs K, Miclotte I, Vermeire S, Darche V, Politis C (2020) Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors. Int J Oral Maxillofac Surg 49(3):317\u2013324. https:\/\/doi.org\/10.1016\/j.ijom.2019.08.007","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"6","key":"8872_CR22","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1016\/j.oooo.2017.09.005","volume":"124","author":"M Henien","year":"2017","unstructured":"Henien M, Carey B, Hullah E, Sproat C, Patel V (2017) Methotrexate-associated osteonecrosis of the jaw: a report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol 124(6):e283\u2013e287. https:\/\/doi.org\/10.1016\/j.oooo.2017.09.005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"8872_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.20517\/2394-4722.2016.06","volume":"2","author":"O Nicolatou-Galitis","year":"2016","unstructured":"Nicolatou-Galitis O, Galiti S, Moschogianni M, Sachanas S, Edwards BJ, Migliorati CA et al.\u00a0(2016) Osteonecrosis of the jaw in a patient with acute myeloid leukemia, who received azacitidine. Journal of Cancer Metastasis and Treatment 2:220\u2013223. https:\/\/doi.org\/10.20517\/2394-4722.2016.06","journal-title":"Journal of Cancer Metastasis and Treatment"},{"issue":"2","key":"8872_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3892\/mco.2016.1100","volume":"6","author":"D Yamamoto","year":"2017","unstructured":"Yamamoto D, Tsubota Y, Utsunomiya T, Sueoka N, Udea A, Endo K et al.\u00a0(2017) Osteonecrosis of the jaw associated with everolimus: a case report. Mol Clin Oncol 6(2):255\u2013257. https:\/\/doi.org\/10.3892\/mco.2016.1100","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"8872_CR25","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.4317\/medoral.22858","volume":"24","author":"C Vallina","year":"2019","unstructured":"Vallina C, Ram\u00edrez L, Torres J, Casa\u00f1as E, Hern\u00e1ndez G, L\u00f3pez-Pintor R-M (2019) Osteonecrosis of the jaws produced by sunitinib: a systematic review. Med Oral Patol Oral Cir Bucal 24(3):e326\u2013e338. https:\/\/doi.org\/10.4317\/medoral.22858","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"2","key":"8872_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.soc.2012.12.001","volume":"22","author":"V Saloura","year":"2013","unstructured":"Saloura V, Langerman A, Rudra S, Chin R, Cohen EEW (2013) Multidisciplinary care of the patient with head and neck cancer. Surg Oncol Clin N Am 22(2):179\u2013215. https:\/\/doi.org\/10.1016\/j.soc.2012.12.001","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"8872_CR27","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","volume":"91","author":"S Marur","year":"2016","unstructured":"Marur S, Forastiere AA (2016) Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc 91(3):386\u2013396. https:\/\/doi.org\/10.1016\/j.mayocp.2015.12.017","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"8872_CR28","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jds.2021.10.019","volume":"17","author":"Y Kojima","year":"2022","unstructured":"Kojima Y, Otsuru M, Hasegawa T, Ueda N, Kirita T, Yamada S\u00a0 ichi et al.\u00a0(2022) Risk factors for osteoradionecrosis of the jaw in patients with oral or oropharyngeal cancer: verification of the effect of tooth extraction before radiotherapy using propensity score matching analysis. J Dent Sci 17(2):1024\u20131029. https:\/\/doi.org\/10.1016\/j.jds.2021.10.019","journal-title":"J Dent Sci"},{"key":"8872_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.oraloncology.2017.11.023","volume":"76","author":"K Kufta","year":"2018","unstructured":"Kufta K, Forman M, Swisher-McClure S, Sollecito TP, Panchal N (2018) Pre-radiation dental considerations and management for head and neck cancer patients. Oral Oncol 76:42\u201351. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.11.023","journal-title":"Oral Oncol"},{"issue":"1","key":"8872_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/00016357.2023.2257316","volume":"82","author":"G Boromand","year":"2024","unstructured":"Boromand G, Haugen-Cange H, Asparusova M, Ekestubbe A, Kjeller G (2024) Long-term follow-up of osteoradionecrosis of the mandible. Acta Odontol Scand 82(1):48\u201354. https:\/\/doi.org\/10.1080\/00016357.2023.2257316","journal-title":"Acta Odontol Scand"},{"issue":"2","key":"8872_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ijrobp.2006.11.059","volume":"68","author":"MA Ben-David","year":"2007","unstructured":"Ben-David MA, Diamante M, Radawski JD, Vinebery KA, Stroup C, Murdoch-Kinch CA et al.\u00a0(2007) Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys 68(2):396\u2013402. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.11.059","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8872_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2024.2353","author":"MC Ward","year":"2024","unstructured":"Ward MC, Petersen CM, Noll J, Bernard MS, Kuremsky JG, Patel A et al.\u00a0(2024) Planned dental extractions after radiation therapy. JAMA Otolaryngology-Head Neck Surg. https:\/\/doi.org\/10.1001\/jamaoto.2024.2353","journal-title":"JAMA Otolaryngology-Head Neck Surg"},{"key":"8872_CR33","doi-asserted-by":"publisher","unstructured":"P. Boffano, Agnone AM, Neirotti F, Bonfiglio R, Brucoli M, Ruslin M et al. (2024) Epidemiology, etiopathogenesis, and management of MRONJ: a European multicenter study. J Stomatol Oral Maxillofac Surg 101931. https:\/\/doi.org\/10.1016\/j.jormas.2024.101931","DOI":"10.1016\/j.jormas.2024.101931"},{"issue":"2","key":"8872_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1902\/jop.2013.130017","volume":"85","author":"V Thumbigere-Math","year":"2014","unstructured":"Thumbigere-Math V, Michalowicz BS, Hodges JS, Tsai ML, Swenson KK, Rockwell L et al.\u00a0(2014) Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw. J Periodontol 85(2):226\u2013233. https:\/\/doi.org\/10.1902\/jop.2013.130017","journal-title":"J Periodontol"},{"key":"8872_CR35","doi-asserted-by":"publisher","unstructured":"J. G. Thomas and A. Ouanounou (2023) Medication-related osteonecrosis of the jaw: a narrative review of risk factors, diagnosis, and management. Front Oral Maxillofacial Med 5 0 https:\/\/doi.org\/10.21037\/fomm-21-106.","DOI":"10.21037\/fomm-21-106"},{"issue":"16","key":"8872_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijerph17165998","volume":"17","author":"G Campisi","year":"2020","unstructured":"Campisi G, Mauceri R, Bertoldo F, Bettini G, Biasotto M, Colella G et al.\u00a0(2020) Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian Consensus Update 2020. Int J Environ Res Public Health 17(16):16. https:\/\/doi.org\/10.3390\/ijerph17165998","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"8872_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00015458.2023.2291295","volume":"124","author":"R Coropciuc","year":"2024","unstructured":"Coropciuc R, Moreno-Rabi\u00e9 C, De Vos W, Van de Casteele E, Marks L, Lenaerts V et al.\u00a0(2024) Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement. Acta Chir Belg 124(1):1\u201311. https:\/\/doi.org\/10.1080\/00015458.2023.2291295","journal-title":"Acta Chir Belg"},{"key":"8872_CR38","unstructured":"National Cancer Strategy 2017 - 2026. Accessed: Jan. 08, 2024. [Online]. Available: https:\/\/www.gov.ie\/en\/publication\/a89819-national-cancer-strategy-2017-2026\/"},{"issue":"1","key":"8872_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41523-021-00323-8","volume":"7","author":"N Vidula","year":"2021","unstructured":"Vidula N, Greenberg S, Petrillo L, Hwang J, Melisko M, Goga A et al.\u00a0(2021) Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid. NPJ Breast Cancer 7(1):113. https:\/\/doi.org\/10.1038\/s41523-021-00323-8","journal-title":"NPJ Breast Cancer"},{"issue":"7","key":"8872_CR40","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1470-2045(12)70226-7","volume":"13","author":"AHG Paterson","year":"2012","unstructured":"Paterson AHG, Anderson SJ, Lembersky BC, Fehrenbacher L, Falkson CI, King KM et al.\u00a0(2012) Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. Lancet Oncol 13(7):734\u2013742. https:\/\/doi.org\/10.1016\/S1470-2045(12)70226-7","journal-title":"Lancet Oncol"},{"issue":"2","key":"8872_CR41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/annonc\/mds277","volume":"24","author":"R Coleman","year":"2013","unstructured":"Coleman R, de Boer R, Eidtmann H, Llombart A, Davidso N, Neven P et al.\u00a0(2013) Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results. Ann Oncol 24(2):398\u2013405. https:\/\/doi.org\/10.1093\/annonc\/mds277","journal-title":"Ann Oncol"},{"issue":"28","key":"8872_CR42","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1200\/JCO.2012.47.2167","volume":"31","author":"G von Minckwitz","year":"2013","unstructured":"von Minckwitz G, M\u00f6bus V, Scneeweiss A, Huober J, Thomssen C, Untch M et al.\u00a0(2013) German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer. J Clin Oncol 31(28):3531\u20133539. https:\/\/doi.org\/10.1200\/JCO.2012.47.2167","journal-title":"J Clin Oncol"},{"issue":"1","key":"8872_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41368-020-00093-2","volume":"12","author":"L He","year":"2020","unstructured":"He L, Sun X, Liu Z, Qiu Y, Niu Y (2020) Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. Int J Oral Sci 12(1):1. https:\/\/doi.org\/10.1038\/s41368-020-00093-2","journal-title":"Int J Oral Sci"},{"issue":"7","key":"8872_CR44","doi-asserted-by":"publisher","first-page":"CD012432","DOI":"10.1002\/14651858.CD012432.pub3","volume":"7","author":"NH Beth-Tasdogan","year":"2022","unstructured":"Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O, Peter J-U (2022) Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev 7(7):CD012432. https:\/\/doi.org\/10.1002\/14651858.CD012432.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"8872_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41415-023-5864-z","volume":"234","author":"EZ Goh","year":"2023","unstructured":"Goh EZ, Beech N, Johnson NR, Batstone M (2023) The dental management of patients irradiated for head and neck cancer. Br Dent J 234(11):11. https:\/\/doi.org\/10.1038\/s41415-023-5864-z","journal-title":"Br Dent J"},{"key":"8872_CR46","unstructured":"PricewaterhouseCoopers (PwC), Conti cyber attack on the HSE: independent post incident review, Health Service Executive (HSE), Report, Dec. 2021. Accessed: Dec. 06, 2023. [Online]. Available: https:\/\/www.lenus.ie\/handle\/10147\/631006"},{"issue":"1","key":"8872_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/sj.bdj.2019.3","volume":"226","author":"T Dietrich","year":"2019","unstructured":"Dietrich T, Ower P, Tank M, West NX, Walte C, Needleman I et al.\u00a0(2019) Periodontal diagnosis in the context of the 2017 classification system of periodontal diseases and conditions - implementation in clinical practice. Br Dent J 226(1):16\u201322. https:\/\/doi.org\/10.1038\/sj.bdj.2019.3","journal-title":"Br Dent J"},{"issue":"1","key":"8872_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1054\/bjom.2001.0684","volume":"40","author":"H Yuasa","year":"2002","unstructured":"Yuasa H, Kawai T, Sugiura M (2002) Classification of surgical difficulty in extracting impacted third molars. Br J Oral Maxillofac Surg 40(1):26\u201331. https:\/\/doi.org\/10.1054\/bjom.2001.0684","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"1","key":"8872_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/OP.22.00302","volume":"19","author":"K Bledsaw","year":"2023","unstructured":"Bledsaw K, Prudowsky ZD, Yang E, Harriehausen CX, Robis J, DeJeanJ et al.\u00a0(2023) A novel oncodental collaborative team: integrating expertise for central line-associated bloodstream infection prevention in pediatric oncology patients. JCO Oncol Pract 19(1):1. https:\/\/doi.org\/10.1200\/OP.22.00302","journal-title":"JCO Oncol Pract"},{"issue":"3","key":"8872_CR50","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s13187-020-01845-8","volume":"37","author":"RR Dang","year":"2022","unstructured":"Dang RR, Brar B, Pasco JM, Rebhun C, Sohn W, Salama A (2022) Dental practice patterns for oral care in medical oncology patients\u2014a survey-based assessment of Massachusetts dentists. J Canc Educ 37(3):555\u2013560. https:\/\/doi.org\/10.1007\/s13187-020-01845-8","journal-title":"J Canc Educ"},{"issue":"Suppl 2","key":"8872_CR51","first-page":"22","volume":"89","author":"LS Taichman","year":"2015","unstructured":"Taichman LS, Gomez G, Inglehart MR (2015) Oral health-related complications of breast cancer treatment: assessing dental hygienists knowledge and professional practice. J Dent Hyg 89(Suppl 2):22\u201337","journal-title":"J Dent Hyg"},{"issue":"9","key":"8872_CR52","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/s00520-020-05440-x","volume":"28","author":"L Drudge-Coates","year":"2020","unstructured":"Drudge-Coates L, Van den Wyngaert T, Schi\u00f8dt M, van Muilekom HAM, Demonty G, Otto S (2020) Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals. Support Care Cancer 28(9):4019\u20134029. https:\/\/doi.org\/10.1007\/s00520-020-05440-x","journal-title":"Support Care Cancer"},{"issue":"1","key":"8872_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/annonc\/mdn554","volume":"20","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA, Kastritis E,Bamia C, Melakopoulos I, Gika D, Roussou M et al.\u00a0(2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20(1):117\u2013120. https:\/\/doi.org\/10.1093\/annonc\/mdn554","journal-title":"Ann Oncol"},{"key":"8872_CR54","first-page":"b147","volume":"77","author":"R Bonacina","year":"2011","unstructured":"Bonacina R, Mariani U, Villa F, Villa A (2011) Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients. J Can Dent Assoc 77:b147","journal-title":"J Can Dent Assoc"},{"issue":"5","key":"8872_CR55","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE,Van Poznak C,Ibrahim T, Stemmer SM, Stopek AT et al.\u00a0(2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23(5):1341\u20131347. https:\/\/doi.org\/10.1093\/annonc\/mdr435","journal-title":"Ann Oncol"},{"issue":"2","key":"8872_CR56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/antibiotics10020195","volume":"10","author":"EM Varoni","year":"2021","unstructured":"Varoni EM, Lombardi N, Villa G, Pispero A, Sardella A, Lodi G (2021) Conservative management of medication-related osteonecrosis of the jaws (MRONJ): a retrospective cohort study. Antibiotics (Basel) 10(2):195. https:\/\/doi.org\/10.3390\/antibiotics10020195","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"8872_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/life10070099","volume":"10","author":"A Marcian\u00f2","year":"2020","unstructured":"Marcian\u00f2 A, Rubino E, Peditto M, Mauceri R, Oteri G (2020) Oral surgical management of bone and soft tissues in MRONJ treatment: a decisional tree. Life (Basel) 10(7):99. https:\/\/doi.org\/10.3390\/life10070099","journal-title":"Life (Basel)"},{"issue":"3","key":"8872_CR58","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1007\/s00784-021-04276-x","volume":"26","author":"K Bertl","year":"2022","unstructured":"Bertl K, Savvidis P, Kukla EB, Schneide S, Zauz K, Bruckmann C et al.\u00a0(2022) Including dental professionals in the multidisciplinary treatment team of head and neck cancer patients improves long-term oral health status. Clin Oral Investig 26(3):2937\u20132948. https:\/\/doi.org\/10.1007\/s00784-021-04276-x","journal-title":"Clin Oral Investig"},{"issue":"4","key":"8872_CR59","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00520-015-2956-6","volume":"24","author":"MO Morais","year":"2016","unstructured":"Morais MO, Elias MRA, Leles CR, DouradoPinezi JC, Mendon\u00e7a EF (2016) The effect of preventive oral care on treatment outcomes of a cohort of oral cancer patients. Support Care Cancer 24(4):1663\u20131670. https:\/\/doi.org\/10.1007\/s00520-015-2956-6","journal-title":"Support Care Cancer"},{"key":"8872_CR60","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12913-024-10859-7","volume":"24","author":"AR Lim","year":"2024","unstructured":"Lim AR, Park W, Moon SJ, Kim MS, Lee S (2024) The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance Service. BMC Health Serv Res 24:412. https:\/\/doi.org\/10.1186\/s12913-024-10859-7","journal-title":"BMC Health Serv Res"},{"key":"8872_CR61","unstructured":"UKCB medication-related osteonecrosis of the jaw (MRONJ) guidance_Dec 2019, BOPA.[Online]. Available: https:\/\/www.bopa.org.uk\/resources\/ukcb-medication-related-osteonecrosis-of-the-jaw-mronj-guidance_dec-2019\/.\u00a0Accessed 09 Jul 2023"},{"issue":"1","key":"8872_CR62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jbo.2012.12.001","volume":"2","author":"I Kuchuk","year":"2013","unstructured":"Kuchuk I, Mazzarello S, Butterfield K, Appleton A, Addison CL, Clemons M (2013) Oral care and the use of bone-targeted agents in patients with metastatic cancers: a practical guide for dental surgeons and oncologists. J Bone Oncol 2(1):38\u201346. https:\/\/doi.org\/10.1016\/j.jbo.2012.12.001","journal-title":"J Bone Oncol"},{"key":"8872_CR63","unstructured":"Medication-related osteonecrosis of the jaw | Scottish Denta. [Online]. Available: https:\/\/www.sdcep.org.uk\/published-guidance\/medication-related-osteonecrosis-of-the-jaw\/.\u00a0Accessed 28 Sep 2022"},{"key":"8872_CR64","doi-asserted-by":"publisher","DOI":"10.32388\/PBUJ6Z","author":"A Bedogni","year":"2023","unstructured":"Bedogni A, Maucei R,Fusco V,Betoldo F, Bettini G, Fede OD et al.\u00a0(2023) Italian Position Paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ). Qeios. https:\/\/doi.org\/10.32388\/PBUJ6Z","journal-title":"Qeios"},{"issue":"7","key":"8872_CR65","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/odi.13160","volume":"25","author":"M Schiodt","year":"2019","unstructured":"Schiodt M, Otto S, Fedele S,Bedogni A, Nicolatou-Galitis O,Guggenberge R et al.\u00a0(2019) Workshop of European task force on medication-related osteonecrosis of the jaw\u2014current challenges. Oral Dis 25(7):1815\u20131821. https:\/\/doi.org\/10.1111\/odi.13160","journal-title":"Oral Dis"},{"issue":"8","key":"8872_CR66","doi-asserted-by":"publisher","first-page":"e0182877","DOI":"10.1371\/journal.pone.0182877","volume":"12","author":"D Lexomboon","year":"2017","unstructured":"Lexomboon D, Karlsson P, Adolfsso J, Ekbo A, Naimi-Akbar A,Bahmanyar S et al.(2017) Consumption and direct costs of dental care for patients with head and neck cancer: a 16-year cohort study. PLoS ONE 12(8):e0182877. https:\/\/doi.org\/10.1371\/journal.pone.0182877","journal-title":"PLoS ONE"},{"issue":"11","key":"8872_CR67","doi-asserted-by":"publisher","first-page":"e1668","DOI":"10.1200\/OP.20.00892","volume":"17","author":"SE Choi","year":"2021","unstructured":"Choi SE, Choudhary A, Sonis S, Villa A (Nov.2021) Benefits of the involvement of dentists in managing oral complications among patients with oral cavity and oropharyngeal cancer: an analysis of claims data. JCO Oncol Pract 17(11):e1668\u2013e1677. https:\/\/doi.org\/10.1200\/OP.20.00892","journal-title":"JCO Oncol Pract"},{"key":"8872_CR68","unstructured":"ESMO Congress 2023. [Online]. Available: https:\/\/oncologypro.esmo.org\/meeting-resources\/esmo-congress?event_resources_filter_form%5Bsearch%5D=harriet%20byrne.\u00a0Accessed 08 Jan 2024"},{"key":"8872_CR69","unstructured":"https:\/\/www.unhcr.org\/external\/component\/header, UNHCR. Accessed: Dec. 06, 2023. [Online]. Available: https:\/\/www.unhcr.org\/external\/component\/header"},{"issue":"1","key":"8872_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12992-018-0373-6","volume":"14","author":"C Ledoux","year":"2018","unstructured":"Ledoux C, Pilot E, Diaz E, Krafft T (Jun.2018) Migrants access to healthcare services within the European Union: a content analysis of policy documents in Ireland. Portugal Spain, Global Health 14(1):57. https:\/\/doi.org\/10.1186\/s12992-018-0373-6","journal-title":"Portugal Spain, Global Health"},{"issue":"1","key":"8872_CR71","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12889-019-6651-2","volume":"19","author":"N Villarroel","year":"2019","unstructured":"Villarroel N, Hannigan A, Severoni S, Puthoopparambil S, MacFarlane A (2019) Migrant health research in the Republic of Ireland: a scoping review. BMC Public Health 19(1):324. https:\/\/doi.org\/10.1186\/s12889-019-6651-2","journal-title":"BMC Public Health"},{"issue":"2","key":"8872_CR72","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/tmi.13845","volume":"28","author":"A MacFarlane","year":"2023","unstructured":"MacFarlane A, Puthoopparmbil SJ,Waagensn E,Sisti LG,Costanzo G,Kayi I et al.\u00a0(2023) Framework for refugee and migrant health research in the WHO European Region. Trop Med Int Health 28(2):90\u201397. https:\/\/doi.org\/10.1111\/tmi.13845","journal-title":"Trop Med Int Health"},{"key":"8872_CR73","unstructured":"Arrivals from Ukraine in Ireland Series 10 - CSO - Central Statistics Office. [Online]. Available: https:\/\/www.cso.ie\/en\/releasesandpublications\/fp\/p-aui\/arrivalsfromukraineinirelandseries10\/.\u00a0Accessed 15 Sep 2023"},{"issue":"1","key":"8872_CR74","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1186\/s12889-020-08749-8","volume":"20","author":"A Lebano","year":"2020","unstructured":"Lebano A, Hame S, Braby H, Gil-Salmer\u00f3n A, Dur\u00e1-Ferrandis E, Garc\u00e9s-Fere J et al.\u00a0(2020) Migrants and refugees health status and healthcare in Europe: a scoping literature review. BMC Public Health 20(1):1039. https:\/\/doi.org\/10.1186\/s12889-020-08749-8","journal-title":"BMC Public Health"},{"key":"8872_CR75","doi-asserted-by":"publisher","first-page":"04111","DOI":"10.7189\/jogh.13.04111","volume":"13","author":"SA Banihashem Rad","year":"2023","unstructured":"Banihashem Rad SA, Esteves Oliveira M, Maklennan A, Castiglia P, Campus G (2023) Higher prevalence of dental caries and periodontal problems among refugees: a scoping review. J Glob Health 13:04111. https:\/\/doi.org\/10.7189\/jogh.13.04111","journal-title":"J Glob Health"},{"issue":"8","key":"8872_CR76","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.healthpol.2021.05.018","volume":"125","author":"SJ Puthoopparambil","year":"2021","unstructured":"Puthoopparambil SJ, Phelan M, MacFarlane A (2021) Migrant health and language barriers: uncovering macro level influences on the implementation of trained interpreters in healthcare settings. Health Policy 125(8):1085\u20131091. https:\/\/doi.org\/10.1016\/j.healthpol.2021.05.018","journal-title":"Health Policy"},{"issue":"1","key":"8872_CR77","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00404-015-3938-0","volume":"294","author":"A von Au","year":"2016","unstructured":"von Au A, Weile U,Stefanovic S,Wallwiene M,Heil J,Golatta M et al.\u00a0(2016) Breast cancer presentation and therapy in migrant versus native German patients: contrasting and convergent data of a retrospective monocentric study. Arch Gynecol Obstet 294(1):145\u2013152. https:\/\/doi.org\/10.1007\/s00404-015-3938-0","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"8872_CR78","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ijc.32726","volume":"147","author":"WMJ Van Hemelrijck","year":"2020","unstructured":"Van Hemelrijck WMJ, De Schutter H, de Valk HAG, Silversmit G, Rosskamp M, Vandenheede H (2020) Breast cancer by migrant background in Belgium: lower risk, but worse survival in women of non-European origin. Int J Cancer 147(2):350\u2013360. https:\/\/doi.org\/10.1002\/ijc.32726","journal-title":"Int J Cancer"},{"issue":"7","key":"8872_CR79","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10654-015-0083-9","volume":"31","author":"UZ Ikram","year":"2016","unstructured":"Ikram UZ, Mackenbach JP, Harding S, Rey G, Bhopal RS, Regidor E et al.\u00a0(2016) All-cause and cause-specific mortality of different migrant populations in Europe. Eur J Epidemiol 31(7):655\u2013665. https:\/\/doi.org\/10.1007\/s10654-015-0083-9","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"8872_CR80","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1634\/theoncologist.2014-0274","volume":"20","author":"M Sze","year":"2015","unstructured":"Sze M, Butow P, Bell M, Vaccaro L, Dog S, Eisenbruch M et al.\u00a0(2015) Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variables. Oncologist 20(5):523\u2013531. https:\/\/doi.org\/10.1634\/theoncologist.2014-0274","journal-title":"Oncologist"},{"key":"8872_CR81","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.2147\/CMAR.S176811","volume":"10","author":"C Liu","year":"2018","unstructured":"Liu C, Wang L, Liu L, Zhuang J, Tang S, Zhang T et al.\u00a0(2018) Efficacy and safety of de-escalation bone- modifying agents for cancer patients with bone metastases: a systematic review and meta-analysis. Cancer Manag Res 10:3809\u20133823. https:\/\/doi.org\/10.2147\/CMAR.S176811","journal-title":"Cancer Manag Res"},{"issue":"9","key":"8872_CR82","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1359\/JBMR.050522","volume":"20","author":"SCLM Cremers","year":"2005","unstructured":"Cremers SCLM, Papapoulos SE, Geldeblom H, Seynaeve C, den Hartigh J, Vemij P et al.\u00a0(2005) Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases. J Bone Miner Res 20(9):1543\u20131547. https:\/\/doi.org\/10.1359\/JBMR.050522","journal-title":"J Bone Miner Res"},{"issue":"9","key":"8872_CR83","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1158\/1078-0432.CCR-11-2944","volume":"18","author":"S Doshi","year":"2012","unstructured":"Doshi S, Sutjandra L, Zheng J, Sohn W, Peterson M, Jang G et al.\u00a0(2012) Denosumab dose selection for patients with bone metastases from solid tumors. Clin Cancer Res 18(9):2648\u20132657. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2944","journal-title":"Clin Cancer Res"},{"issue":"11","key":"8872_CR84","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00520-011-1230-9","volume":"19","author":"N Bouganim","year":"2011","unstructured":"Bouganim N, Dranitsaris G, Amir E, Clemons M (2011) Optimising the use of bone-targeted agents in patients with metastatic cancers: a practical guide for medical oncologists. Support Care Cancer 19(11):1687\u20131696. https:\/\/doi.org\/10.1007\/s00520-011-1230-9","journal-title":"Support Care Cancer"},{"key":"8872_CR85","unstructured":"Treatment by cancer type, NCCN. Accessed: Sep. 13, 2023. [Online]. Available: https:\/\/www.nccn.org\/guidelines\/category_1"},{"issue":"7","key":"8872_CR86","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(13)70174-8","volume":"14","author":"D Amadori","year":"2013","unstructured":"Amadori D, Aglietta M, Alessi B, Gianni L, Ibrahim T, Farina G et al.\u00a0(2013) Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial. Lancet Oncol 14(7):663\u2013670. https:\/\/doi.org\/10.1016\/S1470-2045(13)70174-8","journal-title":"Lancet Oncol"},{"issue":"7","key":"8872_CR87","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jamaoncol.2016.6316","volume":"3","author":"GN Hortobagyi","year":"2017","unstructured":"Hortobagyi GN, Van Poznak C, Karker WG, Gradishar WJ, Chew H, Dakhil Sr et al. (2017) Continued treatment effect of zoledronic acid dosing every 12 vs 4 weeks in women with breast cancer metastatic to bone: the OPTIMIZE-2 randomized clinical trial. JAMA Oncol 3(7):906\u2013912. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6316","journal-title":"JAMA Oncol"},{"key":"8872_CR88","doi-asserted-by":"publisher","first-page":"21","DOI":"10.12688\/hrbopenres.13525.2","volume":"5","author":"P May","year":"2022","unstructured":"May P, Normand C, Matthews S, Kenny RA, Romero-Ortuno R, Tysinger B (2022) Projecting future health and service use among older people in Ireland: an overview of a dynamic microsimulation model in The Irish Longitudinal Study on Ageing (TILDA). HRB Open Res 5:21. https:\/\/doi.org\/10.12688\/hrbopenres.13525.2","journal-title":"HRB Open Res"},{"issue":"6","key":"8872_CR89","first-page":"110","volume":"6","author":"PA Razak","year":"2014","unstructured":"Razak PA, Richard KMJ, Thankachan RP, Hafiz KAA, Kumar KN, Sameer KM (2014) Geriatric oral health: a review article. J Int Oral Health 6(6):110\u2013116","journal-title":"J Int Oral Health"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08872-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:01:51Z","timestamp":1748376111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08872-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":89,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["8872"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08872-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"1 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval application was submitted to the Clinical Research Ethics Committee (CREC), University College Cork (UCC under the title \u201cOral Health Status and Dental Treatment Needs of Oncology Patients Receiving Bone Modifying Agents\u201d. The research team included Dr Harriet Byrne (oral surgery speciality registrar), Professor Seamus O Reilly (consultant in medical oncology) and Professor Richeal N\u00ed Riord\u00e1in (consultant in oral medicine). The stakeholders included University College Cork (UCC) and Health Service Executive (HSE), and the research project was conducted in the Oral Surgery Department, Cork University Dental School and Hospital, Wilton, Co Cork. The study was conducted in accordance with the requirements of the WMA Declaration of Helsinki (2008). Written informed consent will be obtained from all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the data and qualitative findings within this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish"}},{"value":"Authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"693"}}